Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 309

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 309
---
degreespharma.com. Amortization expense for the years ended December
31, 2024, and 2023 was in the amount of $38,502 and $29,157, respectively.

The following table summarizes the estimated
future amortization expense for our patents and website development costs as of December 31, 2024:

    Period 
    Patents  
    Website Development Costs 
  
    2025 
    $6,810  
    $31,761 
  
    2026 
     6,810  
     12,432 
  
    2027 
     6,810  
     3,094 
  
    2028 
     6,810  
     - 
  
    2029 
     6,810  
     - 
  
    Thereafter 
     35,953  
     - 
  
    Total 
    $70,003  
    $47,287 

The Company additionally has $40,172 in capitalized
patent expenses that will become amortizable as the patents they are associated with are awarded.

F-19

6. STOCKHOLDERS’ EQUITY

Pursuant to the Certificate of Incorporation
of 60 Degrees Pharmaceuticals, Inc., the Company’s authorized shares consist of (a) 150,000,000 shares of common stock, par value
$0.0001 per share and (b) 1,000,000 shares of preferred stock, par value $0.0001 per share, of which 80,965 have been designated as Series
A Non-Voting Convertible Preferred Stock (“Series A Preferred Stock”). As of December 31, 2024, 566,908 shares of Common
Stock and 76,480 shares of Series A Preferred Stock are issued and outstanding.

Following stockholder approval in July 2024,
on July 30, 2024, the Company filed an Amendment to the Certificate of Incorporation with the Secretary of State of Delaware to effect
the 1:12 Reverse Stock Split of the issued and outstanding shares of the Company’s common stock, which was effective as of August
12, 2024. As of the effective time of the 1:12 Reverse Stock Split, every twelve (12) issued and outstanding shares of the Company’s
common stock were automatically combined and converted into one (1) issued and outstanding share of the Company’s